v3.26.1
Commitments and Contingencies - License Agreement (Details)
 1 Months Ended 6 Months Ended
Oct. 20, 2025
Right
Aug. 15, 2025
USD ($)
Nov. 30, 2020
USD ($)
Oct. 31, 2020
USD ($)
Nov. 30, 2018
USD ($)
Jun. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
Commitments and Contingencies              
Minimum annual license fee for Patent Family 1     $ 30,000 $ 25,000      
Number of CVR rights | Right 1            
CVR agreement term 7 years            
Percentage of net proceeds 50.00%            
Percentage of holders with rights 30.00%            
License One              
Commitments and Contingencies              
One-time non-refundable fee of license agreement         $ 50,000    
Reimbursement of licensor's patent costs at execution of the license         145,000    
Minimum annual license fee         $ 25,000    
Period within each anniversary of the effective date of the license that minimum annual license fee must be paid         60 days    
Maximum total milestone payments   $ 2,950,000          
Period within which the milestone payments should be paid upon achievement of the milestone   60 days          
Filing of an application for regulatory approval of a clinical diagnostic product or process           $ 100,000  
First regulatory approval of a clinical diagnostic product or process           $ 150,000  
Royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes           3.00%  
Royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes           6.00%  
Royalties calculated as a percentage of any and all sublicense income           30.00%  
Notice period for terminating License           90 days  
Period after the first commercial sale that the License shall continue if not terminated by the company           10 years  
Royalty percentage beyond the term of the License           1.50%  
Minimum annual license fee related to Patent Family 2           $ 10,000  
Paid license amendment fee   $ 75,000          
Phase II clinical trial, Period   60 days          
Phase III clinical trial, Period   60 days          
First commercial sale, Period   60 days          
License Two              
Commitments and Contingencies              
Upon filing of a New Drug Application with the FDA for a product(s) subject to the SKI License           50,000  
Enrollment of first patient in a phase III clinical trial of a therapeutic product or process           125,000  
Accrued license obligations           25,473 $ 0
Change of Control Liquidity Event greater than $100 million              
Commitments and Contingencies              
Change of control liquidity event           100,000,000  
Maximum | Change of Control Liquidity Event between $50 million and $100 million              
Commitments and Contingencies              
Change of control liquidity event           100,000,000  
Minimum | Change of Control Liquidity Event between $50 million and $100 million              
Commitments and Contingencies              
Change of control liquidity event           $ 50,000,000